Add To Watchlist

STENT

The Wire

New Boston Scientific stent approved in Europe

Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries.

FDA approves smaller version of J&J stent

Medical product conglomerate Johnson & Johnson said Monday the Food and Drug Administration approved a smaller version of its drug-coated stent, Cypher.

Appeals court sides with J&J in stent dispute

A federal appeals court on Thursday sided with Johnson & Johnson in a long-running patent dispute with rival Boston Scientific over technology used in artery-opening stents.

Drug, stent makers collaborate on anti-clot study

Several competing drug and medical device makers are starting an international collaboration to find out the best way to prevent potentially deadly blood clots from forming in heart patients who have artery-opening stents implanted.

Pioneer in field of molecular biology dies at 84

Gunther Stent, who helped pioneer the field of molecular biology as one of the first scientists to confirm the structure of DNA, has died. He was 84.

FDA to Seek More Safety Data on Stents

The Food and Drug Administration on Wednesday laid out new guidelines for the testing of drug-coated stents, more than two years after safety concerns curtailed use of the devices.

The Vine
Bioabsorbable stents show promise
Source: scienceblog.com

"In addition to the ABSORB study presenting the longest ever follow up data for a bioabsorbable stent, the investigators used multiple imaging systems, including Optical Coherence Tomography.

Stenting not necessary in late treatment of heart attacks
Source: PhysOrg.com

Two years ago, a major study found that many patients who receive delayed treatment for a heart attack do just as well with drugs alone as they do with drugs plus stents to prop open their blocked arteries.

Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Source: tradingmarkets.com

Marking a major development in the field of interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today that it has received approval from the U.S.

This area needs news. Click here to seed the vine